title: Update on urodynamic bladder dysfunctions after radical hysterectomy for cervical cancer.
abstract: BACKGROUND
  Bladder dysfunctions are a common sequela after radical hysterectomy (RH, former type III sec Piver) ranging from 8 to 80%. This discrepancy, probably, reflects the different bladder function evaluation methods utilized in literature.
  
  
  METHODS
  We searched English-language medical reports published from 1952 to 2010, on MEDLINE. Inclusion criteria were: (1) studies of urological dysfunctions in patients with cervical cancer, treated with type III sec Piver (C2 sec Querleu) radical hysterectomy; (2) use of urodynamic measurement.
  
  
  RESULTS
  The overall incidence of urodynamic bladder dysfunctions is 72%. Follow-up >12 months studies report a high incidence of overactive detrusor low compliance (34%). Eight out of 19 studies show a decrease of the maximal urethral closure pressure (MUCP).
  
  
  CONCLUSIONS
  Follow-up timing seems to be the major factor influencing the wide range of incidence of bladder dysfunction. Urodynamic data could help physicians to formulate appropriate evaluation and treatment for patients having urge incontinence (UI) after RH.
authors.affiliation: Department of Obstetrics and Gynecology, Campus Bio Medico University of Rome, Italy. F.Plotti@unicampus.it
authors.forename: Francesco
authors.initials: F
authors.lastname: Plotti
authors.forename: Roberto
authors.initials: R
authors.lastname: Angioli
authors.forename: Marzio Angelo
authors.initials: MA
authors.lastname: Zullo
authors.forename: Milena
authors.initials: M
authors.lastname: Sansone
authors.forename: Tiziana
authors.initials: T
authors.lastname: Altavilla
authors.forename: Elena
authors.initials: E
authors.lastname: Antonelli
authors.forename: Roberto
authors.initials: R
authors.lastname: Montera
authors.forename: Patrizio
authors.initials: P
authors.lastname: Damiani
authors.forename: Pierluigi
authors.initials: P
authors.lastname: Benedetti Panici
mesh_terms: D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007044:Hysterectomy / Q000009:adverse effects* / Q000379:methods; D001743:Urinary Bladder / Q000503:physiopathology*; D014549:Urinary Incontinence / Q000209:etiology*; D014563:Urodynamics; D002583:Uterine Cervical Neoplasms / Q000601:surgery*